PlantArcBio

Gene Discovery and Gene Editing Platforms for Crop Enhancement

Agriculture & Food Technologies
Public on TASE on Jan, 2021
Follow

Company Overview

Snapshot

Founded in May 2014 by Dror Shalitin, PlantArcBio operates with 11–50 employees. The company has raised $11.15M across 3 funding rounds from 2 investors. PlantArcBio went public on TASE in January 2021.

Business overview

PlantArcBio specializes in gene discovery and RNA interference (RNAi) technologies for agricultural applications. Utilizing its proprietary DIP™ (Direct-In-Plant) and DIPPER™ platforms, the company identifies and develops novel genes and gene-editing targets to enhance crop traits such as yield, drought tolerance, nutrition, and resistance to herbicides and pests. Additionally, PlantArcBio develops RNAi-based biological products as sustainable alternatives to chemical crop protection, serving the agriculture and food technologies sector by improving plant resilience and productivity for climate-adaptive farming practices.

Strategic signal

In February 2026, PlantArcBio announced a licensing collaboration with Helix Sementes e Biotecnologia, a company within the Agroceres Group, to advance high-yield, drought-resilient corn in South America. This partnership signifies a strategic expansion into a key agricultural market and validates PlantArcBio's technology for addressing climate change challenges in crop production, indicating strong commercial momentum and potential for broader market adoption.

Log in to access full profile

Company Intelligence Q&A

When did PlantArcBio go public?
PlantArcBio went public on the TASE in January 2021.
What was a significant recent partnership for PlantArcBio?
In February 2026, PlantArcBio announced a licensing collaboration with Helix Sementes e Biotecnologia, a company within the Agroceres Group, to develop high-yield, drought-resilient corn in South America.
Has PlantArcBio received any recent patent approvals?
In September 2025, PlantArcBio secured patents in the United States and South Korea for its proprietary DIPPER™ platform, advancing gene-editing optimization in crops.
What strategic collaboration did PlantArcBio form in December 2024?
In December 2024, ToolGen and PlantArcBio forged a strategic collaboration to develop gene-edited, herbicide-tolerant soybeans for global markets.
When did PlantArcBio receive USDA-APHIS approval for its herbicide-tolerant gene?
In January 2024, PlantArcBio received USDA-APHIS approval in the US for planting and breeding soybean modified with its novel PPO herbicide-tolerant gene.
Log in to access full profile